Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trial. (2019)

First Author: Blair GW
Attributed to:  Standards for determining the vascular contribution to neurodegeneration funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.eclinm.2019.04.001

PubMed Identifier: 31317131

Publication URI: http://europepmc.org/abstract/MED/31317131

Type: Journal Article/Review

Volume: 11

Parent Publication: EClinicalMedicine

ISSN: 2589-5370